Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B I Rini

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2010
Temsirolimus in VEGF-refractory metastatic renal cell carcinomaM J MacKenzie, B I Rini, P Elson, et al.
Bone Marrow Transplantation|January 13, 2004
Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cellsH Harlin, A S Artz, M Mahowald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancerB I Rini, N J Vogelzang, M C Dumas, et al.
Clinical Genitourinary Cancer|December 17, 2013
Clinical outcome of stereotactic radiosurgery for central nervous system metastases from renal cell carcinomaD J Seastone, P Elson, J A Garcia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
Axitinib dose titration: analyses of exposure, blood pressure and clinical response from a randomized phase II study in metastatic renal cell carcinomaB I Rini, B Melichar, M N Fishman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2007
Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenibI Tamaskar, R Bukowski, P Elson, et al.
Oncogene|May 1, 2012
Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinomaW Du, B M Wright, X Li, et al.
Bone Marrow Transplantation|November 16, 2004
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago ExperienceA S Artz, K Van Besien, T Zimmerman, et al.
British Journal of Cancer|May 23, 2013
Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinomaR J Motzer, B Escudier, R Bukowski, et al.
ESMO Open|April 9, 2022
Efficacy and safety of avelumab plus axitinib in elderly patients with advanced renal cell carcinoma: extended follow-up results from JAVELIN Renal 101Y Tomita, R J Motzer, T K Choueiri, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2010
Temsirolimus in VEGF-refractory metastatic renal cell carcinomaM J MacKenzie, B I Rini, P Elson, et al.
Bone Marrow Transplantation|January 13, 2004
Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cellsH Harlin, A S Artz, M Mahowald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancerB I Rini, N J Vogelzang, M C Dumas, et al.
Clinical Genitourinary Cancer|December 17, 2013
Clinical outcome of stereotactic radiosurgery for central nervous system metastases from renal cell carcinomaD J Seastone, P Elson, J A Garcia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
Axitinib dose titration: analyses of exposure, blood pressure and clinical response from a randomized phase II study in metastatic renal cell carcinomaB I Rini, B Melichar, M N Fishman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2007
Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenibI Tamaskar, R Bukowski, P Elson, et al.
Oncogene|May 1, 2012
Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinomaW Du, B M Wright, X Li, et al.
Bone Marrow Transplantation|November 16, 2004
Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago ExperienceA S Artz, K Van Besien, T Zimmerman, et al.
British Journal of Cancer|May 23, 2013
Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinomaR J Motzer, B Escudier, R Bukowski, et al.
ESMO Open|April 9, 2022
Efficacy and safety of avelumab plus axitinib in elderly patients with advanced renal cell carcinoma: extended follow-up results from JAVELIN Renal 101Y Tomita, R J Motzer, T K Choueiri, et al.
Pageof 4